Differences of electroacupuncture-induced analgesic effect in normal and inflammatory conditions in rats.
It has been reported by Stein et al. that the immune system and peripheral opioid receptors are involved in the control of pain accompanying inflammation. Electroacupuncture (EA) is used to relieve various kinds of pain. However, little is known about the effect of electroacupuncture analgesia (EAA) during hyperalgesia elicited by inflammation. The aim of the present study was to compare (1) the individual variation of EAA, (2) the durability of EAA, and (3) the effect of naloxone on EAA between normal rats and rats subjected to acute inflammatory pain. Carrageenan was subcutaneously administered by intraplantar (i.pl.) injection of the left hind paw to induce a nociceptive response. Nociceptive thresholds were measured using the paw pressure threshold (PPT). Rats received EA at 3 Hz in the left anterior tibial muscles for 1 hour after carrageenan injection. Naloxone was administered by intraperitoneal (i.p.) or i.pl. injection just before EA. EAA was elicited in 15 of 29 normal rats. These rats were divided into responders and non-responders. EAA in the responder group was almost completely antagonized by i.p. injection of naloxone. In contrast, in all the rats with carrageenan-induced inflammation, EAA was elicited, lasted for at least 24 hours after carrageenan injection, and was dose-dependently antagonized by i.pl. injection, but not significantly by i.p. injection of naloxone. It seems likely that the EAA in the rats with carrageenan-induced inflammation differs from that in normal rats, and these findings suggest that peripheral opioid receptors are involved in EAA during inflammatory conditions.
Department of Surgery, Graduate School of Acupuncture and Moxibustion, Meiji University of Oriental Medicine, Funai, Kyoto 629-0392, Japan.
Reina
R
Sekido
Keisou
K
Ishimaru
Masakazu
M
Sakita
D015667:Acupuncture Analgesia; D000818:Animals; D002351:Carrageenan; D015671:Electroacupuncture; D006930:Hyperalgesia / Q000628:therapy*; D007249:Inflammation / Q000139:chemically induced / Q000628:therapy*; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D017288:Pain Threshold; D011312:Pressure; D051381:Rats; D017207:Rats, Sprague-Dawley
D009292:Narcotic Antagonists; D009270:Naloxone; D002351:Carrageenan